Business & Regulation

Vaccine development for COVID-19 may have been rapid, but no one has scrimped on safety.

Pharma hasn’t always covered itself in glory – but as the world scrambles for viable COVID-19 interventions, it has a rare opportunity to rebrand.

Patient perspectives can make a huge difference when designing drug delivery devices that are truly fit for real-world use.

Is the European Union better prepared for future healthcare crises?

The creators of the COVID-19 Curator give their perspectives on the pandemic and how it has changed their day-to-day lives.

With the right partner to help you harness the many benefits, nasal delivery is not to be sniffed at.

New EU “transparency” measures give member states the power to block vaccine exports if manufacturers can’t meet contractual obligations.

We sit down with the British Generics Manufacturers Association's Warwick Smith.

Sitting down with Janssen's David Lee to discuss a new era in immunology R&D.

What factors are driving pharma's move towards digital marketing?